You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Research progress on FOXM1 in ovarian cancer diagnosis and therapeutics
- 2. Application of radiomics-based prediction model to predict preoperative lymph node metastasis in prostate cancer: a systematic review and meta-analysis
- 3. Sentinel lymph node biopsy omission in early-stage breast cancer: current evidence and clinical practice
- 4. Multiple drug resistance caused by germline mutation of exon 27 of BRCA2 gene in triple-negative breast cancer: a case report and literature review
- 5. Case Report: Triple-negative breast cancer with brain and meningeal metastases exhibits spatiotemporal heterogeneity in terms of HER2 expression
- 6. Radiomics models to predict axillary lymph node metastasis in breast cancer and analysis of the biological significance of radiomic features
- 7. FDA approves first twice-yearly injection that prevents HIV infection
- 8. Risk factors for adverse reactions caused by abemaciclib in breast cancer therapy
- 9. Efficacy and safety of Sacituzumab govitecan in solid tumors: a systematic review and meta-analysis
- 10. Scientists find new way to predict how bowel cancer drugs will stop working – paving the way for smarter treatments
Last updated at 15:05 GMT
Hot News Makers
Health/Pharma Companies
-
75268.02
-
46937.60
-
44831.38
-
34524.89
-
17939.82
-
14763.51
-
13488.57
-
12814.14
-
12440.91
-
11046.67
Drugs, Treatments, Trials
-
14289.62
-
5502.69
-
4438.88
-
4235.73
-
3833.01
-
2887.45
-
1190.56
-
975.52
-
773.77
-
750.18
Last updated at 14:10 GMT
